Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
2.
Arch Pharm Res ; 35(9): 1665-71, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23054724

RESUMO

Herpes Simplex Virus type 1 (HSV-1) antibodies are found in up to 90 percent of the general population. About 30% of patients who have been exposed to HSV-1 develop recurrent infections, and this degree is continually increasing. In addition, resistance to all major anti-herpetic drugs such as acyclovir (ACV) has been increasingly reported. These observations underscore the importance of discovering new therapeutic tools for the treatment of HSV-1 infections. Bifidobacterium spp. has been studied in various fields including antibacterial and anticancer effect, but the antiviral activity was studied very little. The aim of this study was to test the antiviral activity of Bifidobacterium spp. against HSV-1. The Bifidobacterium adolescentis SPM 0214 used in this study through the screening of 23 Bifidobacterium spp. by plaque assay was assessed the cell viability assay in Vero cells. We also measured the plaque reduction assay and yield reduction assay after B. adolescentis SPM 0214 treatment at concentrations ranging between 10 and 104 µg/mL. The B. adolescentis SPM 0214 was not toxic to Vero cells, and the inhibition of plaque and yield formation was obviously increased compared to those of the control (no additive). Therefore, these results indicate that antiviral activity of B. adolescentis SPM 0214 against HSV-1.


Assuntos
Antibiose , Bifidobacterium/crescimento & desenvolvimento , Herpesvirus Humano 1/crescimento & desenvolvimento , Adulto , Animais , Antivirais/uso terapêutico , Bifidobacterium/isolamento & purificação , Sobrevivência Celular , Chlorocebus aethiops , Fezes/microbiologia , Herpes Simples/prevenção & controle , Herpesvirus Humano 1/patogenicidade , Humanos , Probióticos/uso terapêutico , República da Coreia , Células Vero , Ensaio de Placa Viral , Adulto Jovem
3.
Arch Pharm Res ; 35(6): 1065-71, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22870816

RESUMO

The objective of this study was to evaluate the antibacterial and anti-inflammatory effect of Bifidobacterium spp. In the first part of the study, the antibacterial activities of live and sonicated cells, from a total of 23 Bifidobacterium species, on the growth of 5 different strain of Staphylococcus aureus. Six strains, of sonicated Bifidobacterium, exhibited antibacterial activity against staphylococci samples, and seven Bifidobacterium strains exhibited antibacterial activity on the growth of S. aureus S.P.-N2. In the second part of the study, we tested the antimicrobial activity, of Bifidobacterium against Propionibacterium acne KCTC3320, using the co-culture method. The loss of P. acnes viability, caused by B. adolescentis SPM0308 and B. longum SPM1207, was 84% and 75%, respectively (*p < 0.05). In the third part of the study, the anti-inflammatory activity of B. adolescentis SPM0308 and B. longum SPM1207 were assessed; nitric oxide (NO), and tumor necrosis factor-α (TNF-α), production were tested using the murine macrophage RAW 264.7 cell line. Treatment of RAW 264.7 cells, with Bifidobacterium, decreased production of NO and TNF-α rather than LPS (100 ng/mL) treatment. The results suggest that B. adolescentis SPM0308 could be used as an effective control for P. acnes KCTC3320, and S. aureus, and reduce the risk of acne vulgaris development. We suggest that B. adolescentis SPM0308 may be a useful probiotic microorganism, for prevention of acne vulgaris, without adverse effects.


Assuntos
Acne Vulgar/terapia , Antibiose , Bifidobacterium/fisiologia , Macrófagos/microbiologia , Propionibacterium acnes/crescimento & desenvolvimento , Acne Vulgar/imunologia , Acne Vulgar/microbiologia , Animais , Antibacterianos/farmacologia , Linhagem Celular , Testes de Sensibilidade a Antimicrobianos por Disco-Difusão , Mediadores da Inflamação/metabolismo , Lipopolissacarídeos/farmacologia , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Camundongos , Testes de Sensibilidade Microbiana , Viabilidade Microbiana , Óxido Nítrico/metabolismo , Propionibacterium acnes/efeitos dos fármacos , Sonicação , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/crescimento & desenvolvimento , Fator de Necrose Tumoral alfa/metabolismo
4.
BMC Med ; 10: 72, 2012 Jul 12.
Artigo em Inglês | MEDLINE | ID: mdl-22788922

RESUMO

BACKGROUND: Probiotic lactic acid bacteria (LAB) support a functional and balanced immune system, and contribute to immune modulatory effects in combatting microbial pathogens, including viruses. Most cervical cancers are associated with anogenital region infection with high-risk (HR) human papillomavirus (HPV). In this study, we analyzed the antiviral activity of Bifidobacterium adolescentis SPM1005-A in the SiHa cervical cancer cell line expressing HPV type 16. METHODS: We assessed the cellular toxicity of B. adolescentis SPM1005-A in SiHa cells by the Trypan blue dye exclusion assay. Cells (3.6 × 105) in culture plates with or without B. adolescentis SPM1005-A in the same type of medium, were incubated with HPV type 16 at a concentration of 5.1 × 107 cfu/ml. For antiviral analysis, we performed quantitative real-time PCR (qRT-PCR) for E6 and E7 oncogene expressions and observed protein levels by immunoblotting. RESULTS: The qRT-PCR results showed that E6 and E7 mRNA levels decreased simultaneously. Western blot analysis revealed that the E6 protein expression slightly decreased after 24 and 48 h, but the level of E7 protein expression appear unaffected compared with that in the control. Decreased HPV16 E6 and E7 mRNA transcript and protein levels were not associated with cell morphology or significant cytotoxic effects. CONCLUSIONS: This study showed that B. adolescentis SPM1005-A had antiviral activity through suppression E6 and E7 oncogene expression. The results suggest that B. adolescentis SPM1005-A could be potential applications of HPV-associated cervical cancer prevention.


Assuntos
Bifidobacterium/imunologia , Papillomavirus Humano 16/imunologia , Infecções por Papillomavirus/imunologia , Probióticos , Neoplasias do Colo do Útero/imunologia , Linhagem Celular Tumoral , Transformação Celular Neoplásica , Feminino , Regulação Viral da Expressão Gênica , Humanos , Proteínas Oncogênicas Virais/antagonistas & inibidores , Proteínas Oncogênicas Virais/biossíntese , Proteínas Oncogênicas Virais/genética , Proteínas E7 de Papillomavirus/antagonistas & inibidores , Proteínas E7 de Papillomavirus/biossíntese , Proteínas E7 de Papillomavirus/genética , Proteínas Repressoras/antagonistas & inibidores , Proteínas Repressoras/biossíntese , Proteínas Repressoras/genética
5.
Arch Pharm Res ; 34(8): 1353-61, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21910058

RESUMO

Pseudomonas aeruginosa exists in various environments, and can cause mild or serious infections resulting in a wide range of symptoms. In this study, we collected bacterial isolates from hospitalized patients and unchlorinated drinking water, in Korea, 2010. The water-borne and clinical isolates were compared using colony morphology, antimicrobial susceptibility testing, and random amplification of polymorphic DNA analysis. We first compared morphological features of the water-borne and clinical isolates. The clearest difference in colony morphology was colony shape; five water-borne isolate colonies (83%) had a smooth, circular morphology, while nine (75%) clinical isolate colonies had a rough, irregular morphology. Minimum inhibitory concentrations analyses were performed to determine antimicrobial resistant patterns; using ceftazidime, gentamicin, tigecycline, chloramphenicol, meropenem, and tobramycin according to Clinical and Laboratory Standard Institute (CLSI, 2009) methodology. All waterborne isolates were not resistant to gentamicin, tobramycin, and meropenem. The clinical isolates were resistant to every antibiotic except chloramphenicol. Genotyping was performed using the repetitive extragenic palindromic polymerase-chain-reaction. The DNA fingerprinting patterns did not reveal genetic similarity between the water-borne and clinical P. aeruginosa isolates. On the contrary, they showed that genetically distinct populations have been established in each of these environments. We have revealed significant morphological, clinical and genetic differences between water-borne and clinical isolates of the same bacterial species.


Assuntos
Antibacterianos/farmacologia , Impressões Digitais de DNA , Água Potável/microbiologia , Farmacorresistência Bacteriana/genética , Infecções por Pseudomonas/microbiologia , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/isolamento & purificação , Idoso , Ceftazidima/farmacologia , Feminino , Genótipo , Gentamicinas/farmacologia , Humanos , Coreia (Geográfico) , Masculino , Meropeném , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Técnicas de Amplificação de Ácido Nucleico , Infecções por Pseudomonas/tratamento farmacológico , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/fisiologia , Tienamicinas/farmacologia
6.
Lipids Health Dis ; 10: 116, 2011 Jul 12.
Artigo em Inglês | MEDLINE | ID: mdl-21745411

RESUMO

BACKGROUND: Recent studies have reported the preventive effects of probiotics on obesity. Among commensal bacteria, bifidobacteria is one of the most numerous probiotics in the mammalian gut and are a type of lactic acid bacteria. The aim of this study was to assess the antiobesity and lipid-lowering effects of Bifidobacterium spp. isolated from healthy Korean on high fat diet-induced obese rats. METHODS: Thirty-six male Sprague-Dawley rats were divided into three groups as follows: (1) SD group, fed standard diet; (2) HFD group, fed high fat diet; and (3) HFD-LAB group, fed high fat diet supplemented with LAB supplement (B. pseudocatenulatum SPM 1204, B. longum SPM 1205, and B. longum SPM 1207; 108 ~ 109 CFU). After 7 weeks, the body, organ, and fat weights, food intake, blood serum levels, fecal LAB counts, and harmful enzyme activities were measured. RESULTS: Administration of LAB reduced body and fat weights, blood serum levels (TC, HDL-C, LDL-C, triglyceride, glucose, leptin, AST, ALT, and lipase levels), and harmful enzyme activities (ß-glucosidase, ß-glucuronidase, and tryptophanase), and significantly increased fecal LAB counts. CONCLUSION: These data suggest that Bifidobacterium spp. used in this study may have beneficial antiobesity effects.


Assuntos
Fármacos Antiobesidade/farmacologia , Bifidobacterium , Hipolipemiantes/farmacologia , Obesidade/prevenção & controle , Probióticos/farmacologia , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Glicemia , Gorduras na Dieta , Fezes/enzimologia , Fezes/microbiologia , Glucuronidase/metabolismo , Leptina/sangue , Lipase/sangue , Lipídeos/sangue , Masculino , Obesidade/sangue , Obesidade/induzido quimicamente , Ratos , Ratos Sprague-Dawley , Triptofanase/metabolismo , Urease/metabolismo , Aumento de Peso/efeitos dos fármacos , alfa-Amilases/sangue , beta-Glucosidase/metabolismo
7.
Arch Oral Biol ; 56(10): 1047-54, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21439550

RESUMO

OBJECTIVE: Dental caries is the main common infectious disease in the human oral cavity. Streptococcus mutans and Streptococcus sobrinus were reported to be the most important etiological factors in human dental caries. Thus, we examined the inhibitory effects of Bifidobacterium spp. cells and culture supernatants against S. mutans and S. sobrinus, including Streptococcus gordonii, and Aggregatibacter actinomycetemcomitans, which is associated with periodontal disease. METHODS: Mutans streptococci or A. actinomycetemcomitans and lactic acid bacteria (LAB) were mixed in 1:1 ratio and then incubated for 90 min at 37°C. After the incubation, the viability of mutans streptococci or A. actinomycetemcomitans was determined by plate count technique. We also investigated the morphological changes of S. mutans treated with LAB using scanning electron microscopy (SEM). RESULTS: In vitro viability of S. mutans, S. sobrinus, S. gordonii, and A. actinomycetemcomitans was affected by human intestinal LAB identified as Bifidobacterium adolescentis SPM1005 and Bifidobacterium longum SPM1207. Especially, B. adolescentis SPM1005 cells at 1.0 × 10(8) CFU had a strong growth-inhibiting effect against S. mutans and induced a 64% loss of its viability (p<0.05). In addition, swollen and disrupted S. mutans were observed after incubation with B. adolescentis SPM1005. However, the culture supernatant of this strain did not show such inhibitory activity. CONCLUSION: B. adolescentis SPM1005 cells decreased the growth of S. mutans, which is a risk factor for dental caries. Therefore, we suggest that this Bifidobacterium strain may be a useful probiotic microorganism for prevention of dental caries that does not have adverse effects.


Assuntos
Antibiose/fisiologia , Bifidobacterium/fisiologia , Cárie Dentária/microbiologia , Streptococcus mutans/fisiologia , Streptococcus sobrinus/fisiologia , Adulto , Aggregatibacter actinomycetemcomitans/fisiologia , Carga Bacteriana , Técnicas Bacteriológicas , Bifidobacterium/classificação , Cárie Dentária/prevenção & controle , Humanos , Lactobacillus/classificação , Lactobacillus/fisiologia , Viabilidade Microbiana , Microscopia Eletrônica de Varredura , Probióticos/uso terapêutico , República da Coreia , Streptococcus gordonii/fisiologia , Streptococcus mutans/ultraestrutura , Temperatura , Fatores de Tempo , Adulto Jovem
8.
Environ Health Toxicol ; 26: e2011016, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22216417

RESUMO

OBJECTIVES: The purpose of this study was to assess the microbiological quality of unchlorinated drinking water in Korea, 2010. One hundred and eighty unchlorinated drinking water samples were collected from various sites in Seoul and Gyeonggi province. METHODS: To investigate bacterial presence, the pour plate method was used with cultures grown on selective media for total bacteria, total coliforms, and Staphylococcus spp., respectively. RESULTS: In the 180 total bacteria investigation, 72 samples from Seoul and 33 samples from Gyeonggi province were of an unacceptable quality (>10(2) CFU/mL). Of all the samples tested, total coliforms were detected in 28 samples (15.6%) and Staphylococcus spp. in 12 samples (6.7%). Most of the coliform isolates exhibited high-level resistance to cefazolin (88.2%), cefonicid (64.7%) and ceftazidime (20.6%). In addition, Staphylococcus spp. isolates exhibited high-level resistance to mupirocin (42%). Species of Pseudomonas, Acinetobacter, Cupriavidus, Hafnia, Rahnella, Serratia, and Yersinia were isolated from the water samples. CONCLUSIONS: The results of this study suggest that consumption of unchlorinated drinking water could represent a notable risk to the health of consumers. As such, there is need for continuous monitoring of these water sources and to establish standards.

9.
Arch Pharm Res ; 33(9): 1425-31, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20945142

RESUMO

We have previously reported that live Bifidobacterium longum SPM1207, a strain isolated from healthy adult Koreans, significantly reduced serum cholesterol in broth and rat. We here examined the effect of oral administration of sonication-killed B. longum SPM1207 on serum cholesterol in rats in order to investigate whether this killed strain could be utilized as a potent probiotics for human and animals. Dietary treatments consisted of 3 treatment groups of 24 rats each randomly assigned to either normal diet, high cholesterol diet and saline (HCS), or high cholesterol diet and sonication-killed B. longum SPM1207 (HCKB) for 3 weeks. Although HDL-cholesterol levels in the serum were not significantly (p > 0.05) different between HCKB rats and HCS rats, total and LDL-cholesterol levels in the serum were significantly (p < 0.05) less increased in HCKB (total: 177.71 mg/dL, LDL-: 60.50 mg/dL) rats when compared to HCS (total: 237.17 mg/dL, LDL-: 71.50 mg/dL) rats. AI was significantly (p < 0.05) lower in HCKB (4.95 mg/dL) rats when compared to HCS (9.22 mg/dL) rats. Body weight increase and relative liver weight were significantly (p < 0.05) lower in HCKB rats when compared to HCS rats. Over the time, high cholesterol diet caused dry feces accompanied by decreased fecal water content (66.00 to 61.94%) but sonication-killed B. longum SPM1207 administration increased fecal water content (71.58 to 74.25%). The results in the current study provide evidence that the sonication-killed cells of B. logum SPM1207 isolated from healthy adult Koreans have a greater potential to be used as a cholesterol-lowering agent. Furthermore, the current study suggest that this killed specific strain may play role in part in blocking the body weight increase and relieving or eliminating constipation.


Assuntos
Anticolesterolemiantes/uso terapêutico , Bifidobacterium/isolamento & purificação , Fezes/microbiologia , Hipercolesterolemia/prevenção & controle , Viabilidade Microbiana , Probióticos/uso terapêutico , Adulto , Animais , Bifidobacterium/crescimento & desenvolvimento , Peso Corporal , Colesterol na Dieta/administração & dosagem , LDL-Colesterol/sangue , Constipação Intestinal/prevenção & controle , Fezes/química , Humanos , Hipercolesterolemia/sangue , Fígado/patologia , Masculino , Tamanho do Órgão , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , República da Coreia , Sonicação , Água/análise , Adulto Jovem
10.
Nutr J ; 9: 5, 2010 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-20137076

RESUMO

BACKGROUND: Constipation is a significant problem in the elderly, specifically nursing home and/or extended-care facility residents are reported to suffer from constipation. Lactic acid bacteria (LAB) are beneficial probiotic organisms that contribute to improved nutrition, microbial balance, and immuno-enhancement of the intestinal tract, as well as diarrhea and constipation effect. The objective of this study was to investigate the efficacy of this LAB supplement in the management of nursing home residents. METHODS: Nineteen subjects (8M, 11F; mean age 77.1 +/- 10.1) suffering with chronic constipation were assigned to receive LAB (3.0 x 10(11) CFU/g) twice (to be taken 30 minutes after breakfast and dinner) a day for 2 weeks in November 2008. Subjects draw up a questionnaire on defecation habits (frequency of defecation, amount and state of stool), and we collected fecal samples from the subjects both before entering and after ending the trial, to investigate LAB levels and inhibition of harmful enzyme activities. Results were tested with SAS and Student's t-test. RESULTS: Analysis of questionnaire showed that there was an increase in the frequency of defecation and amount of stool excreted in defecation habit after LAB treatment, but there were no significant changes. And it also affects the intestinal environment, through significantly increase (p < 0.05) fecal LAB levels. In addition, tryptophanase and urease among harmful enzyme activities of intestinal microflora were significantly decreased (p < 0.05) after LAB treatment. CONCLUSION: LAB, when added to the standard treatment regimen for nursing home residents with chronic constipation, increased defecation habit such as frequency of defecation, amount and state of stool. So, it may be used as functional probiotics to improve human health by helping to prevent constipation.


Assuntos
Bifidobacterium , Constipação Intestinal/tratamento farmacológico , Suplementos Nutricionais , Lactobacillus acidophilus , Casas de Saúde , Pediococcus , Adulto , Fatores Etários , Idoso , Doença Crônica , Constipação Intestinal/microbiologia , Fezes/microbiologia , Feminino , Glucuronidase/efeitos dos fármacos , Glucuronidase/metabolismo , Humanos , Intestinos/efeitos dos fármacos , Intestinos/microbiologia , Coreia (Geográfico) , Masculino , Inquéritos e Questionários , Resultado do Tratamento , Triptofanase/efeitos dos fármacos , Triptofanase/metabolismo , Urease/efeitos dos fármacos , Urease/metabolismo , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA